- Up to 15 patients will be enrolled in the expansion cohort, from which mandatory pre- and post-dose tumor biopsies will be collected for the assessment of pharmacodynamic endpoints, at dose level 8 (160 mg FdCyd+3000 mg THU 1x daily days 1-6 days week 1, days 8-13 week 2, in 21-day cycles)